Research ExplorerPublicationsKomorbidität rheumatischer und hepatologischer Erkrankungen

Komorbidität rheumatischer und hepatologischer Erkrankungen

Standard

Komorbidität rheumatischer und hepatologischer Erkrankungen. / Mayet, W-J; Lohse, A W.

In: Z RHEUMATOL, Vol. 72, No. 6, 01.08.2013, p. 547-54.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Mayet, W-J & Lohse, AW 2013, 'Komorbidität rheumatischer und hepatologischer Erkrankungen', Z RHEUMATOL, vol. 72, no. 6, pp. 547-54. https://doi.org/10.1007/s00393-012-1116-3

APA

Mayet, W-J., & Lohse, A. W. (2013). Komorbidität rheumatischer und hepatologischer Erkrankungen. Z RHEUMATOL, 72(6), 547-54. https://doi.org/10.1007/s00393-012-1116-3

Vancouver

Mayet W-J, Lohse AW. Komorbidität rheumatischer und hepatologischer Erkrankungen. Z RHEUMATOL. 2013 Aug 1;72(6):547-54. https://doi.org/10.1007/s00393-012-1116-3

Bibtex

@article{7477fae224c44003b6fb54275c1ffcac,
title = "Komorbidit{\"a}t rheumatischer und hepatologischer Erkrankungen",
abstract = "The correlation between rheumatic diseases and liver diseases is complex and often not given sufficient attention. There are, however, consequences for diagnosis and therapy. Rheumatic diseases can present with hepatic symptoms while liver diseases can exhibit rheumatic symptoms. Examples of liver diseases as a cause of rheumatic symptoms are viral hepatitis B and C, autoimmune hepatitis and hemochromatosis. As a result of rheumatic diseases, such as adult onset Still's disease and systemic lupus erythematosus, liver dysfunction can occur. Autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis are directly associated with rheumatic diseases and have to be distinguished by way of differential diagnosis. During antirheumatic therapy, serious hepatotoxic side effects have to be expected.",
keywords = "Comorbidity, Evidence-Based Medicine, Humans, Liver Diseases, Prevalence, Rheumatic Diseases, Risk Factors",
author = "W-J Mayet and Lohse, {A W}",
year = "2013",
month = aug,
day = "1",
doi = "10.1007/s00393-012-1116-3",
language = "Deutsch",
volume = "72",
pages = "547--54",
journal = "Z RHEUMATOL",
issn = "0340-1855",
publisher = "D. Steinkopff-Verlag",
number = "6",

}

RIS

TY - JOUR

T1 - Komorbidität rheumatischer und hepatologischer Erkrankungen

AU - Mayet, W-J

AU - Lohse, A W

PY - 2013/8/1

Y1 - 2013/8/1

N2 - The correlation between rheumatic diseases and liver diseases is complex and often not given sufficient attention. There are, however, consequences for diagnosis and therapy. Rheumatic diseases can present with hepatic symptoms while liver diseases can exhibit rheumatic symptoms. Examples of liver diseases as a cause of rheumatic symptoms are viral hepatitis B and C, autoimmune hepatitis and hemochromatosis. As a result of rheumatic diseases, such as adult onset Still's disease and systemic lupus erythematosus, liver dysfunction can occur. Autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis are directly associated with rheumatic diseases and have to be distinguished by way of differential diagnosis. During antirheumatic therapy, serious hepatotoxic side effects have to be expected.

AB - The correlation between rheumatic diseases and liver diseases is complex and often not given sufficient attention. There are, however, consequences for diagnosis and therapy. Rheumatic diseases can present with hepatic symptoms while liver diseases can exhibit rheumatic symptoms. Examples of liver diseases as a cause of rheumatic symptoms are viral hepatitis B and C, autoimmune hepatitis and hemochromatosis. As a result of rheumatic diseases, such as adult onset Still's disease and systemic lupus erythematosus, liver dysfunction can occur. Autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis are directly associated with rheumatic diseases and have to be distinguished by way of differential diagnosis. During antirheumatic therapy, serious hepatotoxic side effects have to be expected.

KW - Comorbidity

KW - Evidence-Based Medicine

KW - Humans

KW - Liver Diseases

KW - Prevalence

KW - Rheumatic Diseases

KW - Risk Factors

U2 - 10.1007/s00393-012-1116-3

DO - 10.1007/s00393-012-1116-3

M3 - SCORING: Zeitschriftenaufsatz

C2 - 23868731

VL - 72

SP - 547

EP - 554

JO - Z RHEUMATOL

JF - Z RHEUMATOL

SN - 0340-1855

IS - 6

ER -